Taiwan Advanced Nanotech Inc. (TPEX:6797)

Market Cap	443.44M -9.0%
Revenue (ttm)	154.37M -21.9%
Net Income	-226.61M
EPS	-7.41
Shares Out	30.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,736
Open	13.95
Previous Close	14.65
Day's Range	13.95 - 14.80
52-Week Range	12.55 - 20.70
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 2, 2026

About Taiwan Advanced Nanotech

Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plates; filling line systems; and molecular biology reagents. It also provides OEM/ODM services. The company was founded in 2004 and is based in Taoyuan Ci...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6797

Financial Performance

In 2025, Taiwan Advanced Nanotech's revenue was 154.37 million, a decrease of -21.87% compared to the previous year's 197.59 million. Losses were -226.61 million, 18.9% more than in 2024.